These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1997482)

  • 1. Assessment of accuracy of PET utilizing a 3-D phantom to simulate the activity distribution of [18F]fluorodeoxyglucose uptake in the human brain.
    Hoffman EJ; Cutler PD; Guerrero TM; Digby WM; Mazziotta JC
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A17-25. PubMed ID: 1997482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction and characterization of scattered events in three-dimensional PET using scanners with retractable septa.
    Cherry SR; Meikle SR; Hoffman EJ
    J Nucl Med; 1993 Apr; 34(4):671-8. PubMed ID: 8455087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution.
    Meltzer CC; Zubieta JK; Links JM; Brakeman P; Stumpf MJ; Frost JJ
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):650-8. PubMed ID: 8964805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatially dependent deadtime losses in high count rate cardiac PET.
    Freedman NM; Bacharach SL; McCord ME; Bonow RO
    J Nucl Med; 1992 Dec; 33(12):2226-31. PubMed ID: 1460521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional imaging characteristics of the HEAD PENN-PET scanner.
    Karp JS; Freifelder R; Geagan MJ; Muehllehner G; Kinahan PE; Lewitt RM; Shao L
    J Nucl Med; 1997 Apr; 38(4):636-43. PubMed ID: 9098216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate attenuation correction despite movement during PET imaging.
    Andersson JL; Vagnhammar BE; Schneider H
    J Nucl Med; 1995 Apr; 36(4):670-8. PubMed ID: 7699463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of varying physical parameters of a PET system on the accuracy of radioactivity quantitation in vivo.
    Herzog H; Rota Kops E; Schmid A; Feinendegen LE
    Med Prog Technol; 1991; 17(3-4):193-8. PubMed ID: 1839849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
    Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography in aging and dementia: effect of cerebral atrophy.
    Chawluk JB; Alavi A; Dann R; Hurtig HI; Bais S; Kushner MJ; Zimmerman RA; Reivich M
    J Nucl Med; 1987 Apr; 28(4):431-7. PubMed ID: 3494824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
    Alavi A; Smith R; Duncan D
    J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
    [No Abstract]   [Full Text] [Related]  

  • 11. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
    Tamminga CA
    Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional glucose metabolic rates in the human brain: a PET study.
    Gulyás B; Trón L; Balkay L; Emri M; Molnár T; Tóth G; Marian T
    Acta Biol Hung; 1996; 47(1-4):157-72. PubMed ID: 9123988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cerebral glucose metabolism determined by positron emission tomography: a revisit.
    Brooks RA; Hatazawa J; Di Chiro G; Larson SM; Fishbein DS
    J Cereb Blood Flow Metab; 1987 Aug; 7(4):427-32. PubMed ID: 3497163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in the quantitation of reoriented cardiac PET images.
    Kuhle WG; Porenta G; Huang SC; Phelps ME; Schelbert HR
    J Nucl Med; 1992 Jun; 33(6):1235-42. PubMed ID: 1597745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance characteristics of an eight-ring whole body PET scanner.
    Rota Kops E; Herzog H; Schmid A; Holte S; Feinendegen LE
    J Comput Assist Tomogr; 1990; 14(3):437-45. PubMed ID: 2186064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic standardization: linear scaling and nonlinear warping of functional brain images.
    Minoshima S; Koeppe RA; Frey KA; Kuhl DE
    J Nucl Med; 1994 Sep; 35(9):1528-37. PubMed ID: 8071705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
    Valk PE; Jagust WJ; Derenzo SE; Huesman RH; Geyer AB; Budinger TF
    Radiology; 1990 Sep; 176(3):783-90. PubMed ID: 2389037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorodeoxyglucose brain metabolism studied by NMR and PET.
    Bolo NR; Brennan KM; Jones RM; Budinger TF
    Ann N Y Acad Sci; 1987; 508():451-9. PubMed ID: 3501936
    [No Abstract]   [Full Text] [Related]  

  • 20. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
    Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
    J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.